July 20, 2022 | Environment, Sustainability, What matters to us
Louise Jones, Sustainability Officer at Cuttsy+Cuttsy celebrates their new silver sustainability rating
Over the past year we have been making practical steps to align Cuttsy+Cuttsy to a more sustainable future. Earlier this month, we completed our first voluntary assessment as part of this goal. EcoVadis is a sustainability ratings provider who partner with companies to supply a globally recognised scorecard and performance improvement tools. The submission required a thorough audit across many of our operations, processes, and carbon footprint.
The results are in and Cuttsy+Cuttsy now rate among the top 25 percent of companies assessed by EcoVadis, scoring us a Silver accreditation. As our first submission, this is slightly mind-blowing.
To say I am over the moon would be an understatement. The team and I have worked incredibly hard, and our commitment to sustainability has clearly been reflected. We are incredibly proud of this score, and we are already working on the objectives to achieve Gold.
We are firm believers in better health for everyone and this cannot be achieved without also considering the health of our planet. This is just the first voluntary disclosure we have conducted this year, there will be plenty more to come. Watch this space.
Cuttsy+Cuttsy are committed to a net zero future, and we will achieve this through accurate carbon disclosures and verifiable science-based targets. We will accomplish this, and I look forward to the day when we announce ‘WE DID IT’.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Explore why long-term clinical trial engagement is a behavioural challenge, showing how proactive support from site teams can help participants stay connected, confident and committed throughout a study.
Patients are often most honest outside the clinic—revealing vital insights that can help clinical trial teams build trust, improve participation and collect better data.
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical endpoints measure.
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.
Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.
